Frequently Asked Questions
The market is segmented based on , By Product (Demineralized Bone Matrix (DBM), Allograft, Bone Morphogenetic Protein (BPM0, Viscosupplementation Products, Synthetic Bone Substitutes, and Others), Application (Osteoarthritis and Degenerative Arthritis, Spinal Fusion, Fracture Recovery, Soft Tissue Injuries, and Maxillofacial and Dental Applications), Type (Knee, Ankle, Hip, Wrist and Shoulder, Spine, and Others), and End-User (Hospitals and Ambulatory Centers, Research and Academic Institute, and Dental Clinics) – Industry Trends and Forecast to 2031.
.
The Global Orthobiologics Market size was valued at USD 8.85 USD Billion in 2023.
The Global Orthobiologics Market is projected to grow at a CAGR of 5.9% during the forecast period of 2024 to 2031.
The major players operating in the market include XTANT MEDICAL, Arthrex , SeaSpine, NuVasive , Bioventus, Kuros Biosciences, K2M , RTI Surgical Holdings , Orthofix Holdings , Globus Medical , Harvest Technologies, Zimmer Biomet, Stryker, Medtronic, DePuy Synthes, Sanofi, SEIKAGAKU CORPORATION, Locate Bio , MTF Biologics, Alphatec Spine , Exactech
-.
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, Rest of South America.
